ArticleInternational journal of molecular sciences2016

Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of Imatinib.

Kazuma Ohyashiki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.